pharma · Renal Insufficiency, Chronic · REVB
REVELATION BIOSCIENCES
REVELATION BIOSCIENCES, INC.
Revelation Biosciences is a pharma organization headquartered in San Diego, USA. It trades on NYSE under ticker REVB. Primary therapeutic focus areas include Renal Insufficiency, Chronic. NovaPharmaNews links 1 clinical
San Diego, USA HQ
2020 Founded
14 Employees
Public company Type
REVB · NYSE Ticker
Company details
- Status
- Public
- HQ
- San Diego, USA
- Founded
- 2020
- Employees
- 14
- Programs
- 1
- Drugs
- 1
- Patents
- 2
Intravenous Gemini
Phase 2 · small molecule · Renal Insufficiency, Chronic
Intravenous Gemini for Renal Insufficiency, Chronic is a Phase 2 program (small_molecule) at REVELATION BIOSCIENCES, INC. with 1 ClinicalTrials.gov record(s).
Internal code RVL-CKD01
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- REVELATION BIOSCIENCES, INC.
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Renal Insufficiency, Chronic
- Status
- completed
- Trials
- 1